TY - JOUR
T1 - Trends in pulmonary valve replacement in children and adults with tetralogy of Fallot
AU - O'Byrne, Michael L.
AU - Glatz, Andrew C.
AU - Mercer-Rosa, Laura
AU - Gillespie, Matthew J.
AU - Dori, Yoav
AU - Goldmuntz, Elizabeth
AU - Kawut, Steven
AU - Rome, Jonathan J.
N1 - Funding Information:
Dr. O’Byrne receives support from the National Institutes of Health ( NIH ) (Grant T32 HL007915 ) and an Entelligence Young Investigator grant. Dr. Mercer-Rosa receives support from the NIH (Grant NIH 3U01HL098153-03S1 ). Dr. Kawut is supported by the NIH (Grant K24 HL103844 ).
Publisher Copyright:
© 2015 Elsevier Inc. All rights reserved.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Operative correction of tetralogy of Fallot frequently results in pulmonary insufficiency and chronic volume overload, which have been linked to increased risk for adverse outcomes. No consensus recommendations for the timing of pulmonary valve replacement (PVR) exist. The aim of this study was to examine the pattern of PVR in the United States from 2004 to 2012. The Pediatric Health Information Systems database was used to perform an observational study of children and adults ≥10 years of age with diagnoses of tetralogy of Fallot who underwent PVR at 35 centers in the United States from 2004 and 2012, to assess the rate of PVR and the age at which is performed. Mixed-effects multivariate regression was used to account for patient-level covariates and center-level covariance. Additional analyses assessed for trends in cost, hospital length of stay (LOS), intensive care unit LOS, and in-hospital mortality over the study period. In total, 799 subjects at 35 centers underwent PVR over the study period. The number of PVRs performed per year increased significantly over the study period. There was significant between-center heterogeneity in age at PVR (p <0.001). Age at PVR, intensive care unit LOS, hospital LOS, and cost did not change over the study period. In conclusion, PVR in patients with tetralogy of Fallot is being performed more frequently, without an accompanying change in the age at PVR or other measurable outcomes. There is significant variability in the age at which PVR is performed among centers across the United States. This highlights the need for additional research guiding the optimal timing of PVR.
AB - Operative correction of tetralogy of Fallot frequently results in pulmonary insufficiency and chronic volume overload, which have been linked to increased risk for adverse outcomes. No consensus recommendations for the timing of pulmonary valve replacement (PVR) exist. The aim of this study was to examine the pattern of PVR in the United States from 2004 to 2012. The Pediatric Health Information Systems database was used to perform an observational study of children and adults ≥10 years of age with diagnoses of tetralogy of Fallot who underwent PVR at 35 centers in the United States from 2004 and 2012, to assess the rate of PVR and the age at which is performed. Mixed-effects multivariate regression was used to account for patient-level covariates and center-level covariance. Additional analyses assessed for trends in cost, hospital length of stay (LOS), intensive care unit LOS, and in-hospital mortality over the study period. In total, 799 subjects at 35 centers underwent PVR over the study period. The number of PVRs performed per year increased significantly over the study period. There was significant between-center heterogeneity in age at PVR (p <0.001). Age at PVR, intensive care unit LOS, hospital LOS, and cost did not change over the study period. In conclusion, PVR in patients with tetralogy of Fallot is being performed more frequently, without an accompanying change in the age at PVR or other measurable outcomes. There is significant variability in the age at which PVR is performed among centers across the United States. This highlights the need for additional research guiding the optimal timing of PVR.
UR - http://www.scopus.com/inward/record.url?scp=84915758764&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2014.09.054
DO - 10.1016/j.amjcard.2014.09.054
M3 - Article
C2 - 25456860
AN - SCOPUS:84915758764
SN - 0002-9149
VL - 115
SP - 118
EP - 124
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 1
ER -